Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Inside the messy middle of January Digital agency’s AI adoption
The promise of AI efficiency versus the messy, financial-based reality is creating ongoing tension as the industry continues to debate whether AI expedites work, scales creative and curbs costs. “Whether or not it does or doesn’t is still completely all over the place,” said Vic Drabicky, founder and CEO at January Digital, an independent media […]
Brands are catching World Cup fever even without official sponsorships
Some smaller U.S. startups, like Crumbl Cookies and Olipop, are getting into the spirit of the World Cup with watch parties and soccer-themed products.
‘Storytelling hierarchy is starting to flatten’: Tribeca Enterprise CEO on why brands are making the festival a must-stop
The south of France isn’t the only place in June CMOs flock to for creative currency.